Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
450,691
-
Share change
-
-218,690
-
Total reported value
-
$3,019,000
-
Price per share
-
$6.72
-
Number of holders
-
13
-
Value change
-
-$678,133
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q1 2014
As of 31 Mar 2014,
IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
450,691 shares.
The largest 10 holders included
BARD ASSOCIATES INC, Revelation Capital Management Ltd., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, REGIONS FINANCIAL CORP, MARATHON CAPITAL MANAGEMENT, BlackRock Fund Advisors, JANE STREET GROUP, LLC, Tower Research Capital LLC, and MORGAN STANLEY.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.